Search Results - "Keir, Gregory J"

Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants by Walsh, Simon L F, Sverzellati, Nicola, Devaraj, Anand, Keir, Gregory J, Wells, Athol U, Hansell, David M

“…To determine high resolution computed tomography (HRCT) patterns and pulmonary function indices which are associated with increased mortality in patients with…”
Get more information

Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry by Jo, Helen E, Glaspole, Ian, Grainge, Christopher, Goh, Nicole, Hopkins, Peter M A, Moodley, Yuben, Reynolds, Paul N, Chapman, Sally, Walters, E Haydn, Zappala, Christopher, Allan, Heather, Keir, Gregory J, Hayen, Andrew, Cooper, Wendy A, Mahar, Annabelle M, Ellis, Samantha, Macansh, Sacha, Corte, Tamera J

“…7The prevalence of idiopathic pulmonary fibrosis (IPF), a fatal and progressive lung disease, is estimated at 1.25-63 out of 100 000, making large population…”
Get full text

Rituximab in severe, treatment-refractory interstitial lung disease by Keir, Gregory J., Maher, Toby M., Ming, Damien, Abdullah, Reza, de Lauretis, Angelo, Wickremasinghe, M., Nicholson, Andrew G., Hansell, David M., Wells, Athol U., Renzoni, Elisabetta A.

“…Background and objective In patients with severe interstitial lung disease (ILD) progressing despite conventional immunosuppression, rituximab, a B‐lymphocyte…”
Get full text

Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial by Saunders, Peter, Tsipouri, Vicky, Keir, Gregory J, Ashby, Deborah, Flather, Marcus D, Parfrey, Helen, Babalis, Daphne, Renzoni, Elisabetta A, Denton, Christopher P, Wells, Athol U, Maher, Toby M

“…Interstitial lung disease (ILD) frequently complicates systemic autoimmune disorders resulting in considerable morbidity and mortality. The connective tissue…”
Get full text

The supportive care needs of people living with pulmonary fibrosis and their caregivers: a systematic review by Lee, Joanna Y T, Tikellis, Gabriella, Corte, Tamera J, Goh, Nicole S, Keir, Gregory J, Spencer, Lissa, Sandford, Debra, Khor, Yet H, Glaspole, Ian, Price, John, Hey-Cunningham, Alison J, Maloney, Jamie, Teoh, Alan K Y, Watson, Alice L, Holland, Anne E

“…People with pulmonary fibrosis often experience a protracted time to diagnosis, high symptom burden and limited disease information. This review aimed to…”
Get full text

An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study by Walsh, Simon LF, Dr, Wells, Athol U, Prof, Sverzellati, Nicola, MD, Keir, Gregory J, MD, Calandriello, Lucio, MD, Antoniou, Katerina M, MD, Copley, Susan J, MD, Devaraj, Anand, MD, Maher, Toby M, PhD, Renzoni, Elizabetta, PhD, Nicholson, Andrew G, Prof, Hansell, David M, Prof

“…Summary Background Mortality in pulmonary sarcoidosis is highly variable and a reliable prognostic algorithm for disease staging and for guiding management…”
Get full text

Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry by Jo, Helen E, Corte, Tamera J, Glaspole, Ian, Grainge, Christopher, Hopkins, Peter M A, Moodley, Yuben, Reynolds, Paul N, Chapman, Sally, Walters, E Haydn, Zappala, Christopher, Allan, Heather, Keir, Gregory J, Cooper, Wendy A, Mahar, Annabelle M, Ellis, Samantha, Macansh, Sacha, Goh, Nicole S

“…Gastroesophageal reflux disease (GORD) is highly prevalent in idiopathic pulmonary fibrosis (IPF) and may play a role in its pathogenesis. Recent IPF treatment…”
Get full text

Pulmonary involvement in Anti‐Neutrophil Cytoplasmic Antibody Associated Vasculitis: A single centre case series by Bell, Peter T., Sheehy, Robert, Droney, Luke, Prain, Kerri, Wong, Richard, Keir, Gregory J.

“…Anti‐Neutrophil Cytoplasmic Antibody associated Vasculitides (AAV) comprise a rare group of disorders in which respiratory tract involvement is variable and…”
Get full text

Right ventricular functional recovery assessment with stress echocardiography and cardiopulmonary exercise testing after pulmonary embolism: a pilot prospective multicentre study by Samaranayake, Chinthaka Bhagya, Upham, John, Tran, Khoa, Howard, Luke S, Nguyen, Sean, Lwin, Myo, Anderson, James, Wahi, Sudhir, Price, Laura C, Wort, Stephen, Li, Wei, McCabe, Colm, Keir, Gregory J

“…BackgroundData on right ventricular (RV) exercise adaptation following acute intermediate and high-risk pulmonary embolism (PE) remain limited. This study…”
Get full text

Unravelling the enigma of systemic lupus erythematosus‐associated ILD by Keir, Gregory J.

“…See related article See related article…”
Get full text

Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia by CORTE, Tamera J, KEIR, Gregory J, MAHER, Toby M, RENZONI, Elizabeth A, SPENCER, Lisa, ELLIOT, Charlie A, BIRRING, Surinder S, O'REILLY, Katherine, GATZOULIS, Michael A, WELLS, Athol U, WORT, Stephen J, DIMOPOULOS, Konstantinos, HOWARD, Luke, CORRIS, Paul A, PARFITT, Lisa, FOLEY, Claire, YANEZ-LOPEZ, Monica, BABALIS, Daphne, MARINO, Philip

“…Pulmonary hypertension (PH) associated with fibrotic idiopathic interstitial pneumonia (IIP; idiopathic pulmonary fibrosis and nonspecific interstitial…”
Get full text

Biomarker signatures for progressive idiopathic pulmonary fibrosis by Clynick, Britt, Corte, Tamera J, Jo, Helen E, Stewart, Iain, Glaspole, Ian N, Grainge, Christopher, Maher, Toby M, Navaratnam, Vidya, Hubbard, Richard, Hopkins, Peter M A, Reynolds, Paul N, Chapman, Sally, Zappala, Christopher, Keir, Gregory J, Cooper, Wendy A, Mahar, Annabelle M, Ellis, Samantha, Goh, Nicole S, De Jong, Emma, Cha, Lilian, Tan, Dino B A, Leigh, Lucy, Oldmeadow, Christopher, Walters, E Haydn, Jenkins, R Gisli, Moodley, Yuben

“…Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease in which circulatory biomarkers have the potential for guiding management in clinical…”
Get full text

Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia by Assayag, Deborah, Adegunsoye, Ayodeji, Sheehy, Robert, Morisset, Julie, Khalil, Nasreen, Johannson, Kerri A., Marcoux, Veronica, Kolb, Martin, Fisher, Jolene H., Manganas, Helene, Wrobel, Jeremy, Wilsher, Margaret, De Boer, Sally, Mackintosh, John, Chambers, Daniel C., Glaspole, Ian, Keir, Gregory J., Lee, Cathryn T., Jablonski, Renea, Vij, Rekha, Strek, Mary E., Corte, Tamera J., Ryerson, Christopher J.

“…Biological sex, gender, and race are important considerations in patients with interstitial lung diseases (ILDs). Does a patient’s sex assigned at birth, and…”
Get full text

Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis by Humphries, Stephen M., Mackintosh, John A., Jo, Helen E., Walsh, Simon L. F., Silva, Mario, Calandriello, Lucio, Chapman, Sally, Ellis, Samantha, Glaspole, Ian, Goh, Nicole, Grainge, Christopher, Hopkins, Peter M. A., Keir, Gregory J., Moodley, Yuben, Reynolds, Paul N., Walters, E. Haydn, Baraghoshi, David, Wells, Athol U., Lynch, David A., Corte, Tamera J.

“…Background and objective Prediction of disease course in patients with progressive pulmonary fibrosis remains challenging. The purpose of this study was to…”
Get full text

Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease by Li, Andrew, Teoh, Alan, Troy, Lauren, Glaspole, Ian, Wilsher, Margaret L, de Boer, Sally, Wrobel, Jeremy, Moodley, Yuben P, Thien, Francis, Gallagher, Henry, Galbraith, Michelle, Chambers, Daniel C, Mackintosh, John, Goh, Nicole, Khor, Yet Hong, Edwards, Adrienne, Royals, Karen, Grainge, Christopher, Kwan, Benjamin, Keir, Gregory J, Ong, Chong, Reynolds, Paul N, Veitch, Elizabeth, Chai, Gin Tsen, Ng, Ziqin, Tan, Geak Poh, Jackson, Dan, Corte, Tamera, Jo, Helen

“…Lung function testing remains a cornerstone in the assessment and management of interstitial lung disease (ILD) patients. The clinical implications of the…”
Get more information

Diagnosis and management of connective tissue disease‐associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand by Jee, Adelle S., Sheehy, Robert, Hopkins, Peter, Corte, Tamera J., Grainge, Christopher, Troy, Lauren K., Symons, Karen, Spencer, Lissa M., Reynolds, Paul N., Chapman, Sally, Boer, Sally, Reddy, Taryn, Holland, Anne E., Chambers, Daniel C., Glaspole, Ian N., Jo, Helen E., Bleasel, Jane F., Wrobel, Jeremy P., Dowman, Leona, Parker, Matthew J.S., Wilsher, Margaret L., Goh, Nicole S.L., Moodley, Yuben, Keir, Gregory J.

“…ABSTRACT Pulmonary complications in CTD are common and can involve the interstitium, airways, pleura and pulmonary vasculature. ILD can occur in all CTD…”
Get full text

Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy by KEIR, Gregory J, MAHER, Toby M, HANSELL, David M, DENTON, Christopher P, ONG, Voon H, SINGH, Suveer, WELLS, Athol U, RENZONI, Elisabetta A

“…In very severe interstitial lung disease associated with connective tissue disease (CTD-ILD), progressing despite maximal conventional immunosuppression, there…”
Get full text

A call for uniformity in implementing the IPAF (interstitial pneumonia with autoimmune features) criteria by Jee, Adelle S, Bleasel, Jane F, Adelstein, Stephen, Keir, Gregory J, Corte, Tamera J

Get full text

Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterization by Keir, Gregory J., Wort, S. John, Kokosi, Maria, George, Peter M., Walsh, Simon L.F., Jacob, Joseph, Price, Laura, Bax, Simon, Renzoni, Elisabetta A., Maher, Toby M., MacDonald, Peter, Hansell, David M., Wells, Athol U.

“…ABSTRACT Background and objective In interstitial lung disease (ILD), pulmonary hypertension (PH) is a major adverse prognostic determinant. Transthoracic…”
Get full text

Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF) by Jee, Adelle S, Adelstein, Stephen, Bleasel, Jane, Keir, Gregory J, Nguyen, MaiAnh, Sahhar, Joanne, Youssef, Peter, Corte, Tamera J

“…The diagnosis of interstitial lung disease (ILD) requires meticulous evaluation for an underlying connective tissue disease (CTD), with major implications for…”
Get full text